Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:16288975rdf:typepubmed:Citationlld:pubmed
pubmed-article:16288975lifeskim:mentionsumls-concept:C0034693lld:lifeskim
pubmed-article:16288975lifeskim:mentionsumls-concept:C0028128lld:lifeskim
pubmed-article:16288975lifeskim:mentionsumls-concept:C0020649lld:lifeskim
pubmed-article:16288975lifeskim:mentionsumls-concept:C0010762lld:lifeskim
pubmed-article:16288975lifeskim:mentionsumls-concept:C0021467lld:lifeskim
pubmed-article:16288975lifeskim:mentionsumls-concept:C0441655lld:lifeskim
pubmed-article:16288975lifeskim:mentionsumls-concept:C0021469lld:lifeskim
pubmed-article:16288975lifeskim:mentionsumls-concept:C1880177lld:lifeskim
pubmed-article:16288975pubmed:issue1lld:pubmed
pubmed-article:16288975pubmed:dateCreated2006-1-17lld:pubmed
pubmed-article:16288975pubmed:abstractTextNitric oxide (NO) production during endotoxemia is associated with decreased total CYP content, CYP 1A1/2, 2B1/2, 2C6, 2C11, 3A1, and 3A2 mRNA, protein expression or activity which is prevented by NO synthase (NOS) inhibitors in rats. This study was conducted to determine if endotoxin-induced hypotension caused by NO production is mediated by inhibition of renal CYP 4A protein expression and activity. In conscious male Sprague-Dawley rats, endotoxin (10 mg/kg, ip) reduced mean arterial pressure (MAP), increased serum and renal nitrite levels, and inducible NOS (iNOS), and decreased renal CYP 4A1/A3 protein and CYP 4A activity. The selective iNOS inhibitor 1,3-PBIT (10 mg/kg, ip; 1h after endotoxin) prevented endotoxin-induced decrease in MAP, renal CYP 4A1/A3 protein level and CYP 4A activity and increase in systemic and renal nitrite production. The selective constitutive NOS (cNOS) inhibitor N(G)-nitro-L-arginine (L-NNA; 20 mg/kg, ip; 1 h after endotoxin) partially attenuated endotoxin-induced decrease in MAP. The selective CYP 4A inhibitor, aminobenzotriazole (50 mg/kg, ip; 1 h after endotoxin) diminished CYP 4A1/A3 protein level and CYP 4A activity. Aminobenzotriazole did not alter the endotoxin-induced decrease in MAP, but it reversed the effect of 1,3-PBIT in preventing endotoxin-induced fall in MAP and CYP 4A activity. These data suggest that the endotoxemia-induced increase in NO production primarily via iNOS suppresses renal CYP 4A expression and activity, and inhibition of iNOS with 1,3-PBIT restores renal CYP 4A protein and activity and MAP presumably due to increased production of arachidonic acid metabolites derived from CYP 4A.lld:pubmed
pubmed-article:16288975pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16288975pubmed:languageenglld:pubmed
pubmed-article:16288975pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16288975pubmed:citationSubsetIMlld:pubmed
pubmed-article:16288975pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16288975pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16288975pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16288975pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16288975pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16288975pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16288975pubmed:statusMEDLINElld:pubmed
pubmed-article:16288975pubmed:monthFeblld:pubmed
pubmed-article:16288975pubmed:issn1089-8603lld:pubmed
pubmed-article:16288975pubmed:authorpubmed-author:EstesAnneAlld:pubmed
pubmed-article:16288975pubmed:authorpubmed-author:MalikKafait...lld:pubmed
pubmed-article:16288975pubmed:authorpubmed-author:YaghiniFaribo...lld:pubmed
pubmed-article:16288975pubmed:authorpubmed-author:TunctanBaharBlld:pubmed
pubmed-article:16288975pubmed:issnTypePrintlld:pubmed
pubmed-article:16288975pubmed:volume14lld:pubmed
pubmed-article:16288975pubmed:ownerNLMlld:pubmed
pubmed-article:16288975pubmed:authorsCompleteYlld:pubmed
pubmed-article:16288975pubmed:pagination51-7lld:pubmed
pubmed-article:16288975pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:16288975pubmed:meshHeadingpubmed-meshheading:16288975...lld:pubmed
pubmed-article:16288975pubmed:meshHeadingpubmed-meshheading:16288975...lld:pubmed
pubmed-article:16288975pubmed:meshHeadingpubmed-meshheading:16288975...lld:pubmed
pubmed-article:16288975pubmed:meshHeadingpubmed-meshheading:16288975...lld:pubmed
pubmed-article:16288975pubmed:meshHeadingpubmed-meshheading:16288975...lld:pubmed
pubmed-article:16288975pubmed:meshHeadingpubmed-meshheading:16288975...lld:pubmed
pubmed-article:16288975pubmed:meshHeadingpubmed-meshheading:16288975...lld:pubmed
pubmed-article:16288975pubmed:meshHeadingpubmed-meshheading:16288975...lld:pubmed
pubmed-article:16288975pubmed:meshHeadingpubmed-meshheading:16288975...lld:pubmed
pubmed-article:16288975pubmed:meshHeadingpubmed-meshheading:16288975...lld:pubmed
pubmed-article:16288975pubmed:year2006lld:pubmed
pubmed-article:16288975pubmed:articleTitleInhibition by nitric oxide of cytochrome P450 4A activity contributes to endotoxin-induced hypotension in rats.lld:pubmed
pubmed-article:16288975pubmed:affiliationDepartment of Pharmacology, Faculty of Pharmacy, Yenisehir Campus, Mersin University, Turkey. brunctan@yahoo.comlld:pubmed
pubmed-article:16288975pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:16288975pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
pubmed-article:16288975pubmed:publicationTypeResearch Support, N.I.H., Extramurallld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16288975lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16288975lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16288975lld:pubmed